V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 160013922 | 160006804 | 1.67 | 85 | Palliative (P) | 2020-02-10 | 2020-02-11 | Carboplatin + Paclitaxel (3 weekly) | 02 | null | CARBOPLATIN + PACLITAXEL | 100621249 |
| 160013923 | 160006805 | 1.8 | 108.1 | Palliative (P) | null | 2017-06-20 | Docetaxel+Gemcitabine (no prior RT) | 01 | N | VIDE | 100944371 |
| 160013926 | 160006806 | 1.59 | 96.7 | Palliative (P) | 2016-04-20 | 2016-04-21 | Imatinib 400mg | 02 | Y | LIPOSOMAL DOXORUBICIN | 101580531 |
| 160013927 | 160006807 | 1.8 | null | Curative (C) | 2018-06-16 | 2018-07-09 | DOXORUBICIN | 02 | N | LIPOSOMAL DOXORUBICIN | 101126755 |
| 160013928 | 160006808 | 1.72 | 67.3 | Palliative (P) | 2020-10-16 | 2020-10-17 | Cisplatin + Pemetrexed | 02 | N | PACLITAXEL | 101699067 |
| 160013929 | 160006809 | 1.66 | 67 | Palliative (P) | 2020-11-14 | 2020-12-01 | Carboplatin + Paclitaxel (3 weekly) | N | N | CARBOPLATIN + PACLITAXEL | 100617018 |
| 160013930 | 160006810 | 1.72 | 75.6 | Palliative (P) | 2019-03-14 | 2019-03-22 | Cisplatin + Pemetrexed | null | N | CISPLATIN + PEMETREXED | 101051479 |
| 160013932 | 160006811 | 1.75 | 59.9 | Neo-adjuvant (N) | 2021-12-07 | 2021-12-28 | Bevacizumab 7.5mg/kg | 02 | N | EW EUROEWING 2012 ARM B VDC | 101003930 |
| 160013933 | 160006812 | null | null | Palliative (P) | 2017-05-18 | 2017-05-24 | Cisplatin + Pemetrexed | null | null | DOXORUBICIN + IFOSFAMIDE | 100821598 |
| 160013934 | 160006813 | null | null | null | 2017-11-09 | 2017-11-10 | Cisplatin + Pemetrexed | 01 | null | CISPLATIN + PEMETREXED | 101679551 |
| 160013935 | 160006814 | 1.78 | 84.6 | null | 2017-06-27 | 2017-06-27 | STS Rhabdomyosarcoma RMS 2005 VAVV | 02 | Y | TRIAL UNSPECIFIED | 101632894 |
| 160013937 | 160006815 | 1.61 | 19.4 | Palliative (P) | 2018-03-17 | 2018-03-24 | Doxorubicin + Ifosfamide | 02 | N | DOXORUBICIN | 100563202 |
| 160013939 | 160006816 | 1.55 | 79.5 | Disease modification (D) | null | 2016-11-11 | CONFIRM TRIAL | 02 | null | CAPECITABINE | 101772001 |
| 160013941 | 160006817 | null | null | Curative (C) | 2017-12-10 | 2017-12-28 | Cisplatin + Pemetrexed | N | N | CISPLATIN + PEMETREXED | 101042440 |
| 160013944 | 160006819 | 1.65 | null | Palliative (P) | 2019-10-05 | 2019-10-18 | CARBOPLATIN + PACLITAXEL | 02 | N | CARBOPLATIN + PACLITAXEL | 100224226 |
| 160013947 | 160006820 | 1.82 | 54.7 | Neo-adjuvant (N) | 2019-05-06 | 2019-05-13 | LIPOSOMAL DOXORUBICIN | 02 | N | TRIAL UNSPECIFIED | 100008530 |
| 160013948 | 160006821 | 1.67 | 77.2 | null | 2019-04-30 | 2019-06-02 | Bevacizumab 7.5mg/kg | null | null | ENZALUTAMIDE | 100862936 |
| 160013950 | 160006822 | 1.72 | 83.7 | Palliative (P) | 2016-07-18 | 2016-07-28 | Vinorelbine (oral) | 1 | N | DOXORUBICIN + ETOPOSIDE + IFOSFAMIDE + VINCRISTINE | 100597235 |
| 160013951 | 160006823 | 1.74 | 67.6 | Curative (C) | 2019-05-06 | 2019-05-22 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101619753 |
| 160013952 | 160006824 | 1.75 | 59.9 | Palliative (P) | 2016-08-10 | 2016-09-10 | ICON8B TRIAL | 02 | N | EW EUROEWING 2012 ARM B VDC | 101411599 |
| 160013953 | 160006825 | 1.72 | 90 | Adjuvant (A) | 2016-10-23 | 2016-10-23 | Doxorubicin + Olaratumab | 02 | N | HYDROXYCARBAMIDE | 100114624 |
| 160013954 | 160006826 | 1.7 | 78.2 | Curative (C) | 2019-03-07 | 2019-03-16 | Docetaxel 75mg/m2 (21 day) | 02 | N | PEMBROLIZUMAB | 101250083 |
| 160013955 | 160006827 | 1.74 | 63.9 | Curative (C) | null | 2017-12-02 | DOXORUBICIN | N | N | LIPOSOMAL DOXORUBICIN | 101087163 |
| 160013956 | 160006828 | 0 | 86.7 | Curative (C) | null | 2020-12-06 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101218897 |
| 160013957 | 160006829 | 1.61 | 46.6 | Palliative (P) | 2018-05-15 | 2018-05-24 | Cisplatin + Pemetrexed | 2 | N | CISPLATIN + PEMETREXED | 100847128 |
| 160013960 | 160006830 | 1.8 | 63.15 | 03 | 2018-01-03 | 2018-01-04 | Doxorubicin + Ifosfamide | 02 | null | PACLITAXEL | 101196572 |
| 160013961 | 160006831 | 1.67 | 70 | Palliative (P) | 2020-01-25 | 2020-02-08 | CARBOPLATIN + PACLITAXEL | null | N | CARBOPLATIN + PACLITAXEL | 100098249 |
| 160013963 | 160006832 | 1.7 | 97.4 | Palliative (P) | 2019-04-11 | 2019-04-28 | Bevacizumab+Carbo+Pacliaxel | 02 | N | CYCLOPHOSPHAMIDE | 101839287 |
| 160013965 | 160006833 | 1.7 | 60.1 | Palliative (P) | 2018-02-23 | 2018-03-02 | Cisplatin + Pemetrexed | 2 | N | LIPOSOMAL DOXORUBICIN | 100285042 |
| 160013967 | 160006834 | 1.8 | 71.5 | Palliative (P) | 2016-10-01 | 2016-10-14 | BEVACIZUMAB + CARBO + PACLITAXEL | 02 | N | PEMETREXED | 100176517 |
| 160013968 | 160006835 | 1.7 | 54.8 | Palliative (P) | 2019-11-17 | 2019-11-18 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101042587 |
| 160013969 | 160006836 | 1.56 | 86.8 | Palliative (P) | 2016-07-25 | 2016-07-25 | STS Rhabdomyosarcoma RMS 2005 IVAVV | 02 | N | VINORELBINE | 100222185 |
| 160013971 | 160006837 | 1.81 | 96.7 | Palliative (P) | null | 2019-10-21 | Liposomal Doxorubicin (Caelyx) | n | N | LIPOSOMAL DOXORUBICIN | 100903584 |
| 160013973 | 160006838 | 1.88 | 94 | Curative (C) | 2017-05-31 | 2017-06-07 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | DOXORUBICIN + OLARATUMAB | 100311451 |
| 160013974 | 160006839 | null | 13.4 | Palliative (P) | 2019-01-10 | 2019-01-10 | Trial Unspecified | 02 | N | TRIAL UNSPECIFIED | 101252949 |
| 160013975 | 160006840 | 1.66 | 94.7 | null | 2018-03-18 | 2018-03-26 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | N | null | LIPOSOMAL DOXORUBICIN | 101040523 |
| 160013976 | 160006841 | 0 | 61 | Palliative (P) | 2016-02-03 | 2016-02-10 | STS Rhabdomyosarcoma RMS 2005 IVAVV | 02 | N | MELPHALAN | 100111522 |
| 160013978 | 160006843 | 1.81 | 66.5 | Palliative (P) | 2016-01-27 | 2016-01-29 | Cisplatin + Pemetrexed | 2 | N | CISPLATIN + PEMETREXED | 100578244 |
| 160013979 | 160006844 | 1.75 | 79.5 | Palliative (P) | 2016-08-31 | 2016-09-15 | Cisplatin + Pemetrexed | N | N | CISPLATIN + PEMETREXED | 101557040 |
| 160013980 | 160006845 | 1.92 | null | Palliative (P) | 2018-03-18 | 2018-03-25 | null | 02 | N | DOXORUBICIN + IFOSFAMIDE | 100030359 |
| 160013981 | 160006846 | null | null | Palliative (P) | 2019-02-27 | 2019-03-19 | Doxorubicin 75mg/m2 | 02 | null | RITUXIMAB | 101190159 |
| 160013983 | 160006847 | 1.66 | 70.8 | 03 | 2019-05-02 | 2019-05-10 | Doxorubicin + Ifosfamide | 02 | null | DOXORUBICIN + IFOSFAMIDE | 100999126 |
| 160013990 | 160006849 | 1.73 | 71 | Palliative (P) | 2017-05-07 | 2017-05-07 | Cisplatin + Pemetrexed | N | N | CISPLATIN + PEMETREXED | 100952673 |
| 160013991 | 160006850 | 1.69 | 70.7 | Neo-adjuvant (N) | 2019-10-16 | 2019-10-17 | NB HRNBL-1 ch14.18/CHO only (trial) | 02 | N | TRIAL UNSPECIFIED | 101036222 |
| 160013992 | 160006851 | 1.75 | 71.1 | Curative (C) | null | 2017-06-26 | Cisplatin + Pemetrexed | N | N | CISPLATIN + PEMETREXED | 101316898 |
| 160013993 | 160006852 | null | 82.8 | null | 2020-02-04 | 2020-02-06 | Doxorubicin 75mg/m2 | null | N | ETOP 13-18 BEAT-MESO TRIAL | 101743858 |
| 160013996 | 160006853 | 1.8 | 66.2 | null | 2018-12-30 | 2018-12-31 | Liposomal Doxorubicin (Caelyx) | 02 | null | CARBOPLATIN + GEMCITABINE | 101493372 |
| 160013997 | 160006854 | 1.91 | 61 | Palliative (P) | 2016-11-28 | 2016-12-04 | Cisplatin + Pemetrexed | Y | N | CISPLATIN + PEMETREXED | 101046120 |
| 160014005 | 160006855 | 1.64 | 83.65 | Curative (C) | 2019-05-15 | 2019-05-22 | AXICABTAGENE CILOLEUCEL | 02 | N | LIPOSOMAL DOXORUBICIN | 100066039 |
| 160014006 | 160006856 | 1.7 | 63 | null | 2020-11-26 | 2020-11-26 | Paclitaxel 7 day | 02 | N | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 101695620 |